Antiretroviral Prophylaxis for Newborns Born to HIV-Positive Mothers

Introduction to Prophylaxis

The American Academy of Pediatrics recommends that all newborns born to HIV-positive mothers should receive antiretroviral prophylaxis initiated as soon as possible after birth, ideally within 6-12 hours of delivery, with a full 6-week course of zidovudine (ZDV) as the standard regimen 1, 2, 3

The Centers for Disease Control and Prevention recommends starting ARV prophylaxis immediately after birth, preferably within 6 hours but certainly by 12 hours after delivery, to maximize efficacy 3, 5
The effectiveness of prophylaxis decreases significantly with delayed initiation—after 48 hours, efficacy is substantially reduced, according to the MMWR Recommendations and Reports 5
By 14 days of age, HIV infection is already established in most infected infants, making later prophylaxis ineffective, as stated by the MMWR Recommendations and Reports 5

The American Academy of Pediatrics recommends a 6-week course of zidovudine (ZDV) as the cornerstone of neonatal prophylaxis 1, 2, 3
This 6-week regimen should be provided to the family with careful administration instructions before hospital discharge, as recommended by the American Academy of Pediatrics 1, 2, 3
The full course must be completed even if the infant appears healthy, according to the American Academy of Pediatrics 1, 3

For infants born to mothers who received adequate prenatal ARV therapy, the mother should have received combination antiretroviral therapy during pregnancy and intravenous ZDV during labor, as recommended by the American Academy of Pediatrics 7
For infants born to mothers who received no or inadequate ARV therapy, these high-risk infants require more aggressive prophylaxis, including at minimum, the standard 6-week ZDV regimen initiated as soon as possible after delivery, according to the MMWR Recommendations and Reports 5, 8
Some experts recommend combination antiretroviral prophylaxis for these high-risk infants, though definitive efficacy data are limited, as stated by the MMWR Recommendations and Reports 5, 8

Infants born to HIV-positive mothers should not breastfeed under any circumstances in resource-rich settings, as recommended by the American Academy of Pediatrics 1, 2, 3
All care of HIV-exposed newborns should be performed in consultation with specialists experienced in pediatric HIV infection, according to the American Academy of Pediatrics 1, 2, 3
Early diagnostic testing should be performed to identify infected infants so treatment can be initiated promptly, as recommended by the MMWR Recommendations and Reports and the American Academy of Pediatrics 5, 7

Never delay prophylaxis while awaiting confirmatory HIV testing results, as the window for effective prophylaxis is narrow, according to the American Academy of Pediatrics 1, 3
Do not assume oral ZDV during labor provides equivalent protection to intravenous ZDV, as intravenous administration ensures rapid, stable drug levels in both mother and infant during delivery, as stated by the MMWR Recommendations and Reports 8
Do not discontinue prophylaxis prematurely, as the full 6-week course is essential even if early infant HIV testing is negative, according to the American Academy of Pediatrics 1, 3